<SEC-DOCUMENT>0001213900-24-039126-index.html : 20240502 <SEC-HEADER>0001213900-24-039126.hdr.sgml : 20240502 <ACCEPTANCE-DATETIME>20240502161605 ACCESSION NUMBER: 0001213900-24-039126 CONFORMED SUBMISSION TYPE: S-3 PUBLIC DOCUMENT COUNT: 5 FILED AS OF DATE: 20240502 DATE AS OF CHANGE: 20240502 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Protara Therapeutics, Inc. CENTRAL INDEX KEY: 0001359931 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 204580525 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-279067 FILM NUMBER: 24908512 BUSINESS ADDRESS: STREET 1: 345 PARK AVENUE SOUTH STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10010 BUSINESS PHONE: 646-844-0337 MAIL ADDRESS: STREET 1: 345 PARK AVENUE SOUTH STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10010 FORMER COMPANY: FORMER CONFORMED NAME: ArTara Therapeutics, Inc. DATE OF NAME CHANGE: 20200110 FORMER COMPANY: FORMER CONFORMED NAME: PROTEON THERAPEUTICS INC DATE OF NAME CHANGE: 20060420 </SEC-HEADER> <DOCUMENT> <TYPE>S-3 <SEQUENCE>1 <FILENAME>ea0205012-s3_protara.htm <DESCRIPTION>REGISTRATION STATEMENT <TEXT> Document 1 - file: ea0205012-s3_protara.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>ea020501201ex5-1_protara.htm <DESCRIPTION>OPINION OF SULLIVAN & CROMWELL LLP <TEXT> Document 2 - file: ea020501201ex5-1_protara.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>3 <FILENAME>ea020501201ex23-1_protara.htm <DESCRIPTION>CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM <TEXT> Document 3 - file: ea020501201ex23-1_protara.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-FILING FEES <SEQUENCE>4 <FILENAME>ea020501201ex-fee_protara.htm <DESCRIPTION>CALCULATION OF FILING FEE TABLE <TEXT> Document 4 - file: ea020501201ex-fee_protara.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>image_001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: image_001.jpg
</DOCUMENT> </SEC-DOCUMENT>